CLINICAL EVALUATION OF TECHNETIUM-99M LABELLED HUMAN POLYCLONAL IMMUNOGLOBULIN G FOR MUSCULOSKELETAL INFECTION

Authors

  • Chanika SRITARA Division of Radiotherapy and Nuclear Medicine. Department of Radiology
  • Opas SINPHURMSUKSKUL Department of Orthopaedics. Faculty of Medicine, Ramathibodi Hospital
  • Vipa BOONKITTICHAROEN Division of Radiotherapy and Nuclear Medicine. Department of Radiology
  • Pornchai MULPRUK Department of Orthopaedics. Faculty of Medicine, Ramathibodi Hospital
  • Rojana SIRISRIRO Division of Radiotherapy and Nuclear Medicine. Department of Radiology
  • Payap CHOKESUWATTANASKUL Division of Radiotherapy and Nuclear Medicine. Department of Radiology
  • Daungpen PUCHINDA Division of Radiotherapy and Nuclear Medicine. Department of Radiology
  • Anna Ngonrath Na AYUDHYA Division of Radiotherapy and Nuclear Medicine. Department of Radiology
  • Putthiporn CHOUPLYWECH Division of Radiotherapy and Nuclear Medicine. Department of Radiology
  • Puangtong KRIPHIBUL Division of Radiotherapy and Nuclear Medicine. Department of Radiology

Abstract

BACKGROUND: Three-phase bone scan is highly sensitive in detecting infection of the musculoskeleton. However, its low specificity necessitates the search for a more definite measure. This study was designed to determine the sensitivity and the specificity of 99mTc- labelled polyclonal human IgG (HIG) for the detection of infection of the musculoskeleton and to compare these to that of conventional three-phase bone scintigraphy.

METHODS: Thirty-four patients with suspected infection of the musculoskeleton underwent 99mTc-labelled polyclonal human IgG (HIG) scintigraphy 48 hours after 3-phase bone scintigraphy. Both scans were graded on a five-point scale by visual interpretation. The final diagnosis was established by means of bacteriologic culture, histopathologic analysis of surgical specimen or clinical follow-up (follow-up time of 28 ±13 months). There were 44 sites evaluated. Receiver operating characteristic (ROC) curve analysis was generated for both modalities.

RESULTS: At their optimal threshold levels (score 33) of the HIG scan, the sensitivity, specificity, accuracy, likelihood ratios and area under the ROC curve were 84.61%, 96.77%, 93.18%, 26.23, and 0.967, respectively, while those of the 3-phase bone scan were 100%. 87.10%. 90.70%, 7.75, and 0.941, respectively. No adverse reaction was encountered.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Tumech SS, Tohmeh AG. Nuclear medicine techniques in septic arthritis and osteomyelitis. Rheum Dis Clin North Am 1991:17:559-83.

Al-Sheikh W, Sfakianakis GN, Mnaymneh W, et al. Subacute and chronic bone infection: diagnosis using In-111, Ga-67 and Tc-99m MDP bone scintigraphy, and radiography. Radiology 1985:155:501-6.

Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med 1994:24:128-141.

Vorne M, Soini I, Lantto T, Paakkinen S. Technetium-99m HMPAO-labelled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate. J Nucl Med 1989; 30:1332-6.

El Esper I, Dacquet V. Paillard J, Bascoulergue G, Tahon MM. Fonroget J. Te -HMPAO-labelled leucocyte scintigraphy in suspected chronic osteomyelitis related to an orthopedic device: clinical usefulness. Nucl Med Comm 1992:13: 799-805.

Weissman BN. Current topics in the radiology of joint replacement surgery. Radiol Clin North Am 1990;28:1111-34

Wukich DK, Abreu SH, Callaghan JJ. et al. Diagnosis of infection by preoperative scintigraphy with indium-labelled white blood cells. J Bone Joint Surg [Am] 1987: 69:1353-60.

Datz FL, Taylor AT. Cell labelling: techniques and clinical utility. In: Freeman LM, ed. Freeman & Johnson’s clinical radionuclide imaging, 3rd edition. Orlando: Grune & stratton 1984:1785-913.

Goodwin DA. New methods for localizing infection: a role for avidin-biotin? J Nucl Med 1992:33:1816-8.

Sakaha H, Reynolds JC, Carrasquillo JA, et al. In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patients. J Nucl Med 1989;30:1311-7.

Reske SN. Marrow scintigraphy. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment. Edinburgh: Churchill Livingstone, 1994: 705-9.

Peters AM. The choice of and appropriate agent for imaging inflammation. Nucl Med Commun 1996;17:455-8.

Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997;4:334-5.

Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148: 839-43.

Kaim A, Maurer T, Ochsner P. Jundt G, Kirsch E, Mueller-Brand J. chronic complicated osteomyelitis of the appendicular skeleton: diagnosis with technetium-99m labelled monoclonal antigranulocyte antibody-immunoscintigraphy. Eur J Nucl Med 1997;24:732-8.

Seybold K, Locher JT, Coosemans C, Andres RY, Schubiger PA, Blauentein P. Immunoscintigraphic localization of inflammatory lesions: clinical experience. EurJ Nucl Med 1988:13:587-93.

Lind P, Langsteger W, Koltringer PK, Dimai HP, Pass] R, Eber O. Immunoscintigraphy of inflammatory processes with a technetium-99-m-labelled - monoclonal antigranuclocyte antibody (MAb BW 250/183). J Nucl Med 1990;31:417-23.

Hotze AL, Briete B, Overbeck B, et al. Technetium-99m-labelled anti-granulocyte antibodies in suspected bone infections. J Nucl Med 1992:;33:526-31.

Oyen WJG, Boerman OC, van der Laken C, Calessens RAMJ, van der Meer JWM. Corstens FJM. The uptake mechanisms of inflammation and _infection-localizing agents. Eur J Nucl Med 1996;23:459-65.

Pons F, Sanmarti R, Herranz R, Collado A, Piera C, Vidal-Sicart S, Munoz-Gomex J, SetoainJ. Scintigraphic evaluation of the severity of inflammation of the joints with 99Tcm-HIG in rheumatoid arthritis. Nucl Med Commun 1996;17:523-8.

Demirkol MO, Adalet I, Unal SN, Tozun R, Cnatez S. 99Tcm-polyclonal IgG scintigraphy in the detection of infected hip and knee prostheses. Nucl Med Commun 1997:18:543-8.

Palermo F, Boccaletto F, Paolin A, et al. Comparison of Technetium-99m-MDP. Technetium-99m-WBC and Technetium-99m-HIG in Musculoskeletal Inflammation. J Nucl Mex 1998;39:516-21.

Ang Es, Sundram FX, Goh ASW, AW SE. 99mTc-polyclonal IgG and99mTe nanocolloid scans in orthopaedics: a comparison with conventional bone scan. Nucl Med Commun 1993;14:419-32.

Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and Technetium-99m Antigranulocyte Antibody Scintigraphy in Chronic Osteomyelitis. J Nucl Med 1998;39:2145-52.

Lonneux M, Sibomana M, Pauwels S., Gregoire V. Current data and perspectives on positron emission tomography oncology-radiation therapy. Cancer-Radiother 1999;3(4):275-88.

Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, bomanjiJ, Das S. Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection. Eur J Nucl Med 1997:24(5):553-6.

Downloads

Published

2023-04-13

How to Cite

1.
SRITARA C, SINPHURMSUKSKUL O, BOONKITTICHAROEN V, MULPRUK P, SIRISRIRO R, CHOKESUWATTANASKUL P, et al. CLINICAL EVALUATION OF TECHNETIUM-99M LABELLED HUMAN POLYCLONAL IMMUNOGLOBULIN G FOR MUSCULOSKELETAL INFECTION. ASEAN J Radiol [Internet]. 2023 Apr. 13 [cited 2024 Dec. 21];7(1):35-46. Available from: https://asean-journal-radiology.org/index.php/ajr/article/view/551

Issue

Section

Original Article